Intracranial microembolic signals might be a potential risk factor for cognitive impairment

Jing Yan1,2,3,4, Zhaoxia Li1,2,3,4, Melissa Wills5

  • 1Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.

Neurological Research
|August 19, 2021
PubMed

Insights

Microembolic signals (MES) are linked to cognitive impairment in neurological patients. Higher MES detection rates were observed in those with cognitive deficits, suggesting a potential correlation.

Area of Science:

  • Neurology
  • Neuroimaging
  • Vascular Neurology

Background:

  • Cognitive impairment is a significant concern in patients with neurological disorders.
  • Microembolic signals (MES) are indicators of cerebral microembolization.
  • The relationship between MES and cognitive function requires further elucidation.

Purpose of the Study:

  • To investigate the association between MES and cognitive impairment.
  • To utilize a 30-minute MES monitoring test in conjunction with cognitive assessments.

Main Methods:

  • Retrospective review of patients undergoing MES monitoring via dual-channel transcranial Doppler (TCD).
  • Cognitive function assessed using the Montreal Cognitive Assessment (MoCA); impairment defined as MoCA score < 26.
  • MES identification based on International Consensus Group criteria.

Main Results:

  • Of 159 patients with analyzable data, 72 had cognitive impairment.
  • MES positive rate was significantly higher in patients with cognitive impairment (47%) compared to those without (18.4%).
  • MES were independently associated with lower MoCA scores (OR, 7.36; P < 0.0001).

Conclusions:

  • A potential correlation exists between MES and cognitive impairment in neurological patients.
  • MES may serve as a biomarker for cognitive decline.
  • Further research is needed to confirm if continuous microembolization causes progressive cognitive impairment.

Related Concept Videos